IE
MIST icon

Israel Englander’s Milestone Pharmaceuticals MIST Stock Holding History

Israel Englander’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,600
Closed -$226K – 6851
2022
Q3 		$226K Buy
+24,600
New +$187K ﹤0.01% 5571

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Israel Englander's MIST Position: Q2 2026 in Review

Israel Englander increased its Milestone Pharmaceuticals (MIST) stake by 103% in Q2 2026, buying an estimated $2.55M and bringing the position to 3,142,219 shares worth $4.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3154.

Israel Englander first reported a position in MIST in Q2 2019 and has held it in 27 quarters since. The position peaked at $8.57M in Q3 2022. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Israel Englander held 3,142,219 shares of Milestone Pharmaceuticals worth $4.21M as of Q2 2026.
  • Israel Englander bought 1,597,894 Milestone Pharmaceuticals shares in Q2 2026, an estimated $2.55M.
  • Milestone Pharmaceuticals made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3154 holding.
  • Israel Englander first reported a position in Milestone Pharmaceuticals in Q2 2019 and has held it in 27 quarters since.
  • Israel Englander's Milestone Pharmaceuticals position peaked at $8.57M in Q3 2022.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.